MedTrace Logo

Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing

NCT01370187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2011-06-14

No results posted yet for this study

Summary

The aim of the current study is to evaluate the effect of Montelukast in treatment of acute bronchiolitis and postbronchiolitis viral induced wheezing of infants 3 to 12 months of age in Bandar Abbas Children' hospital.

Conditions

  • Bronchiolitis
  • Wheezing
  • Cough

Interventions

DRUG

Montelukast

Montelukast 4mg daily for 2 months

Sponsors & Collaborators

  • Hormozgan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Ali Asghar Parhiz, Resident · Hormzgan University of Medical Sciences (HUMS)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-04-30
Completion
2011-06-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01370187 on ClinicalTrials.gov